Guest Post: Upcoming Therapeutics Initiative One Day Course - Bringing Best Evidence to Clinicians
There is still space to sign up for the Therapeutics Initiative annual one day drug therapy course being held at Surrey Memorial Hospital on Saturday Oct 27, 2018.
This popular conference provides physicians, pharmacists, nurse practitioners, nurses, and other health professionals with up-to-date, evidence-based, practical information on prescription drug therapy.
UBC Therapeutics Initiative faculty and internationally renowned guests will review best evidence for therapeutic issues important to pharmacy, primary care and specialty medicine. Small group case-based workshops facilitate skill building for individual practitioners and for people working in interdisciplinary teams.
Highlights for this year will include epidemiologist Dr. Kay Dickersin from Johns Hopkins University in Baltimore. Dr. Dickersin has built her career studying factors that influence research integrity, has led many clinical trials and has published widely on systematic reviews. She was one of the co-creators of the Cochrane Collaboration in 1993 and has a longstanding interest in supporting consumer and patient engagement in health research
Dr. Dee Mangin is a professor in Family Medicine at McMaster University and has a broad range of research interests. She has specialized in studying rational prescribing, innovative models of primary care delivery, incorporating evidence into patient centred practice and the interplay of science, policy and commerce on the nature of care. Before moving from New Zealand to Canada, Dr. Mangin was the Director of the Primary Care Unit at the University of Otago, Christchurch, and lead important evaluations of primary care reforms in New Zealand.
Some of the subjects we’ll cover this year include:
- How do we know what is evidence?
- What is the evidence for drugs for corticosteroid-associated osteoporosis?
- Prescriber liability when clinical care diverges from clinical practice guidelines
- Sacred monsters: evidence, guidelines, and the nature of good care
- Shingles vaccines
- Why you should not follow SPRINT guidelines for hypertension
More information and registration information
Alan Cassels has been immersed in pharmaceutical policy research and healthcare journalism for 24 years, mostly researching and writing about how prescription drugs are regulated, marketed, prescribed and used. In 2018 Alan Cassels joined UBC’s Therapeutics Initiative as their Communications Director, producing therapeutics letters and other pharmaceutical-related education for doctors and pharmacists.
Guest Post Disclaimer
ReadLinks Guest Posts are intended to expose the public and pharmacy professionals to a diverse range of knowledge, and expertise, with the goal of expanding awareness of issues related to public safety and pharmacy practice. While the College enforces strict Guest Post Submission Guidelines, the views and opinions expressed in this article are those of the author(s) and do not necessarily reflect the official standards or positions of the College of Pharmacists of British Columbia.